Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
105,780,468
-
Share change
-
+7,248,394
-
Total reported value
-
$4,275,244,101
-
Put/Call ratio
-
161%
-
Price per share
-
$40.42
-
Number of holders
-
308
-
Value change
-
+$258,303,501
-
Number of buys
-
133
-
Number of sells
-
180
Institutional Holders of ISIS PHARMACEUTICALS INC - COM (ISIS) as of Q3 2015
As of 30 Sep 2015,
ISIS PHARMACEUTICALS INC - COM (ISIS) was held by
308 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
105,780,468 shares.
The largest 10 holders included
FMR LLC, Clearbridge Investments, LLC, VANGUARD GROUP INC, BAILLIE GIFFORD & CO, BB BIOTECH AG, WADDELL & REED FINANCIAL INC, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, STATE STREET CORP, and FIRST TRUST ADVISORS LP.
This page lists
308
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.